Loading...

Payam Nahid, MD, MPH

Title(s)Professor, Medicine
SchoolSchool of Medicine
Address1001 Potrero Ave
San Francisco CA 94110
Phone628-206-5464
ORCID ORCID Icon0000-0003-2811-1311 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, IrvineM.D.1997School of Medicine
    Scripps Clinic & Research FoundationResidency2001Internal Medicine
    San Diego State UniversityM.P.H.2004Epidemiology
    University of California, San FranciscoFellowship 2004Pulmonary and Critical Care Medicine

    Collapse Overview 
    Collapse Overview
    Dr. Nahid is Professor in Residence in the Division of Pulmonary and Critical Care Medicine, Director of the UCSF Center for Tuberculosis (https://tb.ucsf.edu), Associate Director of Clinical Trials Operations in the UCSF Office of Research, and Medical Director of the UCSF CTSA Trials Innovation Network Hub. His research includes the conduct of clinical trials and translational research in TB with the goal of improving the care of patients with TB and HIV/TB worldwide. Dr. Nahid leads NIH and CDC-funded field studies of new TB diagnostics, Phase 2 and 3 clinical trials in TB therapeutics and latent TB infection treatment implementation studies in partnership with the Vietnam National TB Program, the Vietnam National Lung Hospital, the Hanoi Lung Hospital, Cho Ray Hospital and the Vietnam National Institute of Hygiene and Epidemiology. Dr. Nahid also oversees NIH and BMGF-funded TB biomarker discovery and qualification programs to identify improved biomarkers of treatment effect. Dr. Nahid serves as Chair of the CDC-TBTC Core Science Group and has led the WHO Task Force for New TB Drugs and Treatment Regimens. He leads and has contributed to the development of U.S. and international practice guidelines for the treatment of TB, and provides clinical TB consultation and trainings as part of the UCSF Curry International TB Center of Excellence.

    Collapse Research 
    Collapse Research Activities and Funding
    Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)
    NIH/NIAID U01AI152087Aug 21, 2020 - May 31, 2025
    Role: Co-Principal Investigator
    DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial
    NIH/NIAID U01AI152980Aug 21, 2020 - May 31, 2025
    Role: Principal Investigator
    TB Research And Mentorship Program (TB RAMP)
    NIH/NIAID R25AI147375Aug 19, 2020 - Jul 31, 2025
    Role: Principal Investigator
    Sputum Transcriptomic Expression Profiling in Study 31: Express 31
    NIH/NIAID R01AI127300Aug 3, 2017 - Jul 31, 2022
    Role: Principal Investigator
    TB Surrogate Markers for Assessing Reponse to Treatment (TB SMART Study)
    NIH/NIAID R01AI104589Feb 12, 2013 - Jan 31, 2018
    Role: Principal Investigator
    Real-Time Reagent-Free Noninvasive Diagnosis of Tuberculosis
    NIH/NIAID R43AI098335Jul 1, 2012 - Jun 30, 2014
    Role: Co-Principal Investigator
    Interplay of strain and ethnicity in the immune response to M. tuberculosis
    NIH/NHLBI K23HL092629Sep 28, 2007 - Aug 31, 2013
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications
    Collapse Global Health
    Collapse Websites
    Collapse In The News
    Collapse Faculty Mentoring

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Reply to Chang and Yew. Am J Respir Crit Care Med. 2020 09 01; 202(5):778-779. Sotgiu G, Battista Migliori G, Menzies D, Mase S, Chorba T, Seaworth B, Nahid P. PMID: 32374628.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Protocol for the 3HP Options Trial: a hybrid type 3 implementation-effectiveness randomized trial of delivery strategies for short-course tuberculosis preventive therapy among people living with HIV in Uganda. Implement Sci. 2020 Aug 12; 15(1):65. Kadota JL, Musinguzi A, Nabunje J, Welishe F, Ssemata JL, Bishop O, Berger CA, Patel D, Sammann A, Katahoire A, Nahid P, Belknap R, Phillips PPJ, Namusobya J, Kamya M, Handley MA, Kiwanuka N, Katamba A, Dowdy D, Semitala FC, Cattamanchi A. PMID: 32787925.
      View in: PubMed   Mentions:    Fields:    
    3. Summary for Clinicians: 2019 Clinical Practice Guideline Summary for the Treatment of Drug-Resistant Tuberculosis. Ann Am Thorac Soc. 2020 08; 17(8):911-917. Berger CA, Alipanah N, Kheir F, Ruminjo JK, Nahid P, Thomson C. PMID: 32464069.
      View in: PubMed   Mentions:    Fields:    
    4. Identification of Mycobacterium tuberculosis Peptides in Serum Extracellular Vesicles from Persons with Latent Tuberculosis Infection. J Clin Microbiol. 2020 May 26; 58(6). Mehaffy C, Kruh-Garcia NA, Graham B, Jarlsberg LG, Willyerd CE, Borisov A, Sterling TR, Nahid P, Dobos KM. PMID: 32245831.
      View in: PubMed   Mentions:    Fields:    
    5. The continued hunt for the elusive standard short regimen for treatment of multidrug-resistant tuberculosis. Eur Respir J. 2020 03; 55(3). Cegielski JP, Nahid P, Sotgiu G. PMID: 32198274.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet Respir Med. 2020 04; 8(4):383-394. Lan Z, Ahmad N, Baghaei P, Barkane L, Benedetti A, Brode SK, Brust JCM, Campbell JR, Chang VWL, Falzon D, Guglielmetti L, Isaakidis P, Kempker RR, Kipiani M, Kuksa L, Lange C, Laniado-Laborín R, Nahid P, Rodrigues D, Singla R, Udwadia ZF, Menzies D. PMID: 32192585.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    7. Triumph and Tragedy of 21st Century Tuberculosis Drug Development. N Engl J Med. 2020 03 05; 382(10):959-960. Thwaites G, Nahid P. PMID: 32130819.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Advances in clinical trial design: Weaving tomorrow's TB treatments. PLoS Med. 2020 02; 17(2):e1003059. Lienhardt C, Nunn A, Chaisson R, Vernon AA, Zignol M, Nahid P, Delaporte E, Kasaeva T. PMID: 32106220.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial. Contemp Clin Trials. 2020 03; 90:105938. Dorman SE, Nahid P, Kurbatova EV, Goldberg SV, Bozeman L, Burman WJ, Chang KC, Chen M, Cotton M, Dooley KE, Engle M, Feng PJ, Fletcher CV, Ha P, Heilig CM, Johnson JL, Lessem E, Metchock B, Miro JM, Nhung NV, Pettit AC, Phillips PPJ, Podany AT, Purfield AE, Robergeau K, Samaneka W, Scott NA, Sizemore E, Vernon A, Weiner M, Swindells S, Chaisson RE. PMID: 31981713.
      View in: PubMed   Mentions:    Fields:    
    10. The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials. PLoS Med. 2019 12; 16(12):e1002884. Vernon A, Fielding K, Savic R, Dodd L, Nahid P. PMID: 31821323.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Treatment of Drug-Susceptible Tuberculosis. Clin Chest Med. 2019 12; 40(4):763-774. Zha BS, Nahid P. PMID: 31731983.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    12. Residential urban tree canopy is associated with decreased mortality during tuberculosis treatment in California. Sci Total Environ. 2020 Apr 01; 711:134580. Blount RJ, Pascopella L, Barry P, Zabner J, Stapleton EM, Flood J, Balmes J, Nahid P, Catanzaro DG. PMID: 32000313.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsPHPublic Health
    13. Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline. Am J Respir Crit Care Med. 2019 11 15; 200(10):e93-e142. Nahid P, Mase SR, Migliori GB, Sotgiu G, Bothamley GH, Brozek JL, Cattamanchi A, Cegielski JP, Chen L, Daley CL, Dalton TL, Duarte R, Fregonese F, Horsburgh CR, Ahmad Khan F, Kheir F, Lan Z, Lardizabal A, Lauzardo M, Mangan JM, Marks SM, McKenna L, Menzies D, Mitnick CD, Nilsen DM, Parvez F, Peloquin CA, Raftery A, Schaaf HS, Shah NS, Starke JR, Wilson JW, Wortham JM, Chorba T, Seaworth B. PMID: 31729908.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    14. Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance. PLoS Med. 2019 09; 16(9):e1002915. Lienhardt C, Vernon AA, Cavaleri M, Nambiar S, Nahid P. PMID: 31490921.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    15. Multidrug-resistant tuberculosis - Authors' reply. Lancet. 2019 07 27; 394(10195):299-300. Menzies D, Benedetti A, Migliori GB, Nahid P, Seaworth B. PMID: 31354139.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Feasibility of Direct Sputum Molecular Testing for Drug Resistance as Part of Tuberculosis Clinical Trials Eligibility Screening. Diagnostics (Basel). 2019 May 30; 9(2). Alipanah N, Shete PB, Nguyen H, Nguyen NV, Luu L, Pham T, Nguyen H, Nguyen P, Tran MC, Pham N, Phan H, Phillips PPJ, Cattamanchi A, Nahid P. PMID: 31151255.
      View in: PubMed   Mentions:
    17. Sensitive electrochemiluminescence (ECL) immunoassays for detecting lipoarabinomannan (LAM) and ESAT-6 in urine and serum from tuberculosis patients. PLoS One. 2019; 14(4):e0215443. Broger T, Tsionksy M, Mathew A, Lowary TL, Pinter A, Plisova T, Bartlett D, Barbero S, Denkinger CM, Moreau E, Katsuragi K, Kawasaki M, Nahid P, Sigal GB. PMID: 30998715.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    18. Advances in clinical trial design for development of new TB treatments: A call for innovation. PLoS Med. 2019 03; 16(3):e1002769. Lienhardt C, Nahid P. PMID: 30901322.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    19. Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape. PLoS Med. 2019 03; 16(3):e1002767. Phillips PPJ, Mitnick CD, Neaton JD, Nahid P, Lienhardt C, Nunn AJ. PMID: 30901331.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection. Am J Respir Crit Care Med. 2019 03 01; 199(5):564-571. Keshavjee S, Amanullah F, Cattamanchi A, Chaisson R, Dobos KM, Fox GJ, Gendelman HE, Gordon R, Hesseling A, Le Van H, Kampmann B, Kana B, Khuller G, Lewinsohn DM, Lewinsohn DA, Lin PL, Lu LL, Maartens G, Owen A, Protopopova M, Rengarajan J, Rubin E, Salgame P, Schurr E, Seddon JA, Swindells S, Tobin DM, Udwadia Z, Walzl G, Srinivasan S, Rustomjee R, Nahid P. PMID: 30335466.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    21. Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis. Nat Med. 2019 Jan; 25(1):190. Imperial MZ, Nahid P, Phillips PPJ, Davies GR, Fielding K, Hanna D, Hermann D, Wallis RS, Johnson JL, Lienhardt C, Savic RM. PMID: 30429542.
      View in: PubMed   Mentions:    Fields:    
    22. A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis. J Clin Microbiol. 2018 12; 56(12). Sigal GB, Pinter A, Lowary TL, Kawasaki M, Li A, Mathew A, Tsionsky M, Zheng RB, Plisova T, Shen K, Katsuragi K, Choudhary A, Honnen WJ, Nahid P, Denkinger CM, Broger T. PMID: 30257899.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    23. A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis. Nat Med. 2018 11; 24(11):1708-1715. Imperial MZ, Nahid P, Phillips PPJ, Davies GR, Fielding K, Hanna D, Hermann D, Wallis RS, Johnson JL, Lienhardt C, Savic RM. PMID: 30397355.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    24. The association between Cytomegalovirus co-infection with Pneumocystis pneumonia and mortality in immunocompromised non-HIV patients. Clin Respir J. 2018 Nov; 12(11):2590-2597. Korkmaz Ekren P, Töreyin ZN, Nahid P, Doskaya M, Caner A, Turgay N, Zeytinoglu A, Toz S, Bacakoglu F, Guruz Y, Erensoy S. PMID: 30244544.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    25. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet. 2018 09 08; 392(10150):821-834. Ahmad N, Ahuja SD, Akkerman OW, Alffenaar JC, Anderson LF, Baghaei P, Bang D, Barry PM, Bastos ML, Behera D, Benedetti A, Bisson GP, Boeree MJ, Bonnet M, Brode SK, Brust JCM, Cai Y, Caumes E, Cegielski JP, Centis R, Chan PC, Chan ED, Chang KC, Charles M, Cirule A, Dalcolmo MP, D'Ambrosio L, de Vries G, Dheda K, Esmail A, Flood J, Fox GJ, Fréchet-Jachym M, Fregona G, Gayoso R, Gegia M, Gler MT, Gu S, Guglielmetti L, Holtz TH, Hughes J, Isaakidis P, Jarlsberg L, Kempker RR, Keshavjee S, Khan FA, Kipiani M, Koenig SP, Koh WJ, Kritski A, Kuksa L, Kvasnovsky CL, Kwak N, Lan Z, Lange C, Laniado-Laborín R, Lee M, Leimane V, Leung CC, Leung EC, Li PZ, Lowenthal P, Maciel EL, Marks SM, Mase S, Mbuagbaw L, Migliori GB, Milanov V, Miller AC, Mitnick CD, Modongo C, Mohr E, Monedero I, Nahid P, Ndjeka N, O'Donnell MR, Padayatchi N, Palmero D, Pape JW, Podewils LJ, Reynolds I, Riekstina V, Robert J, Rodriguez M, Seaworth B, Seung KJ, Schnippel K, Shim TS, Singla R, Smith SE, Sotgiu G, Sukhbaatar G, Tabarsi P, Tiberi S, Trajman A, Trieu L, Udwadia ZF, van der Werf TS, Veziris N, Viiklepp P, Vilbrun SC, Walsh K, Westenhouse J, Yew WW, Yim JJ, Zetola NM, Zignol M, Menzies D. PMID: 30215381.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    26. Tuberculosis. Emergency Management of Infectious Diseases. 2018 Aug 9; 308-318. Robert Blount, Payam Nahid, Adithya Cattamanchi. .
      View in: Publisher Site   Mentions:
    27. Application of multiplexed ion mobility spectrometry towards the identification of host protein signatures of treatment effect in pulmonary tuberculosis. Tuberculosis (Edinb). 2018 09; 112:52-61. Kedia K, Wendler JP, Baker ES, Burnum-Johnson KE, Jarsberg LG, Stratton KG, Wright AT, Piehowski PD, Gritsenko MA, Lewinsohn DM, Sigal GB, Weiner MH, Smith RD, Jacobs JM, Nahid P. PMID: 30205969.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    28. Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies. PLoS Med. 2018 07; 15(7):e1002595. Alipanah N, Jarlsberg L, Miller C, Linh NN, Falzon D, Jaramillo E, Nahid P. PMID: 29969463.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    29. Does discovery of differentially culturable M tuberculosis really demand a new treatment paradigm? Longitudinal analysis of DNA clearance from sputum. BMC Infect Dis. 2018 07 03; 18(1):293. Walter ND, Moore CM, Kayigire XA, Dide-Agossou C, Worodria W, Huang L, Everett CK, Schoolnik GS, Nahid P, Davis JL. PMID: 29970012.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    30. Interplay of strain and race/ethnicity in the innate immune response to M. tuberculosis. PLoS One. 2018; 13(5):e0195392. Nahid P, Jarlsberg LG, Kato-Maeda M, Segal MR, Osmond DH, Gagneux S, Dobos K, Gold M, Hopewell PC, Lewinsohn DM. PMID: 29787561.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    31. Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial. EBioMedicine. 2017 Nov; 25:112-121. Sigal GB, Segal MR, Mathew A, Jarlsberg L, Wang M, Barbero S, Small N, Haynesworth K, Davis JL, Weiner M, Whitworth WC, Jacobs J, Schorey J, Lewinsohn DM, Nahid P. PMID: 29100778.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    32. Traffic-Related Air Pollution and All-Cause Mortality during Tuberculosis Treatment in California. Environ Health Perspect. 2017 09 29; 125(9):097026. Blount RJ, Pascopella L, Catanzaro DG, Barry PM, English PB, Segal MR, Flood J, Meltzer D, Jones B, Balmes J, Nahid P. PMID: 28963088.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    33. Second generation multiple reaction monitoring assays for enhanced detection of ultra-low abundance Mycobacterium tuberculosis peptides in human serum. Clin Proteomics. 2017; 14:21. Mehaffy C, Dobos KM, Nahid P, Kruh-Garcia NA. PMID: 28592925.
      View in: PubMed   Mentions:
    34. Clinical and bacteriological characteristics associated with clustering of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2017 07 01; 21(7):766-773. Feng JY, Jarlsberg LG, Salcedo K, Rose J, Janes M, Lin SG, Osmond DH, Jost KC, Soehnlen MK, Flood J, Graviss EA, Desmond E, Moonan PK, Nahid P, Hopewell PC, Kato-Maeda M. PMID: 28513421.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    35. Impact of Euro-American sublineages of Mycobacterium tuberculosis on new infections among named contacts. Int J Tuberc Lung Dis. 2017 05 01; 21(5):509-516. Feng JY, Jarlsberg LG, Rose J, Grinsdale JA, Janes M, Higashi J, Osmond DH, Nahid P, Hopewell PC, Kato-Maeda M. PMID: 28399965.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    36. Vitamin D Deficiency in Patients Referred for Evaluation of Obstructive Sleep Apnea. J Clin Sleep Med. 2017 Apr 15; 13(4):607-612. Salepci B, Caglayan B, Nahid P, Parmaksiz ET, Kiral N, Fidan A, Comert SS, Dogan C, Gungor GA. PMID: 27998376.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    37. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. Lancet Respir Med. 2017 Mar 15. Dheda K, Gumbo T, Maartens G, Dooley KE, McNerney R, Murray M, Furin J, Nardell EA, London L, Lessem E, Theron G, van Helden P, Niemann S, Merker M, Dowdy D, Van Rie A, Siu GK, Pasipanodya JG, Rodrigues C, Clark TG, Sirgel FA, Esmail A, Lin HH, Atre SR, Schaaf HS, Chang KC, Lange C, Nahid P, Udwadia ZF, Horsburgh CR, Churchyard GJ, Menzies D, Hesseling AC, Nuermberger E, McIlleron H, Fennelly KP, Goemaere E, Jaramillo E, Low M, Jara CM, Padayatchi N, Warren RM. PMID: 28344011.
      View in: PubMed   Mentions: 102     Fields:    
    38. Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trials. Clin Pharmacol Ther. 2017 Aug; 102(2):321-331. Savic RM, Weiner M, MacKenzie WR, Engle M, Whitworth WC, Johnson JL, Nsubuga P, Nahid P, Nguyen NV, Peloquin CA, Dooley KE, Dorman SE. PMID: 28124478.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    39. First in vivo magnetic particle imaging of lung perfusion in rats. Phys Med Biol. 2017 05 07; 62(9):3510-3522. Zhou XY, Jeffris KE, Yu EY, Zheng B, Goodwill PW, Nahid P, Conolly SM. PMID: 28218614.
      View in: PubMed   Mentions: 13     Fields:    Translation:Animals
    40. Target regimen profiles for treatment of tuberculosis: a WHO document. Eur Respir J. 2017 01; 49(1). Lienhardt C, Nahid P, Rich ML, Bansbach C, Kendall EA, Churchyard G, González-Angulo L, D'Ambrosio L, Migliori GB, Raviglione M. PMID: 28122858.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    41. Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model. PLoS Med. 2017 Jan; 14(1):e1002202. Kendall EA, Shrestha S, Cohen T, Nuermberger E, Dooley KE, Gonzalez-Angulo L, Churchyard GJ, Nahid P, Rich ML, Bansbach C, Forissier T, Lienhardt C, Dowdy DW. PMID: 28045934.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    42. Tuberculosis Treatment. International Encyclopedia of Public Health. 2017 Jan 1; 267-276. Payam Nahid, Philip C. Hopewell. .
      View in: Publisher Site   Mentions:
    43. Treatment of non-cavitary pulmonary tuberculosis with shortened fluoroquinolone-based regimens: a meta-analysis. Int J Tuberc Lung Dis. 2016 11; 20(11):1522-1528. Alipanah N, Cattamanchi A, Menzies R, Hopewell PC, Chaisson RE, Nahid P. PMID: 27776595.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    44. Treatment of Drug-Susceptible Tuberculosis. Ann Am Thorac Soc. 2016 11; 13(11):2060-2063. Dela Cruz CS, Lyons PG, Pasnick S, Weinstock T, Nahid P, Wilson KC, Thomson CC. PMID: 27831799.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    45. Reply to Alffenaar et al. Clin Infect Dis. 2017 01 01; 64(1):105-106. Peloquin CA, Dorman SE, Vernon A, Battista Migliori G, Nahid P. PMID: 27789610.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    46. Xpert MTB/RIF Assay Shows Faster Clearance of Mycobacterium tuberculosis DNA with Higher Levels of Rifapentine Exposure. J Clin Microbiol. 2016 12; 54(12):3028-3033. Jayakumar A, Savic RM, Everett CK, Benator D, Alland D, Heilig CM, Weiner M, Friedrich SO, Martinson NA, Kerrigan A, Zamudio C, Goldberg SV, Whitworth WC, Davis JL, Nahid P. PMID: 27733634.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsCTClinical Trials
    47. Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis. 2016 10 01; 63(7):853-67. Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A. PMID: 27621353.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCellsPHPublic Health
    48. The ERS-endorsed official ATS/CDC/IDSA clinical practice guidelines on treatment of drug-susceptible tuberculosis. Eur Respir J. 2016 10; 48(4):963-971. Sotgiu G, Nahid P, Loddenkemper R, Abubakar I, Miravitlles M, Migliori GB. PMID: 27587550.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    49. Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays. BMC Public Health. 2016 08 25; 16(1):875. Blount RJ, Tran MC, Everett CK, Cattamanchi A, Metcalfe JZ, Connor D, Miller CR, Grinsdale J, Higashi J, Nahid P. PMID: 27558397.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    50. Urban tree coverage associated with reduced mortality among tuberculosis (TB) patients undergoing treatment in California. ISEE Conference Abstracts. 2016 Aug 17; 2016(1). Robert J Blount*, Lisa Pascopella, Pennan Barry, Dan Meltzer, Jenny Flood, Paul B English, Mark R Segal, Payam Nahid, John Balmes, Donald G Catanzaro. .
      View in: Publisher Site   Mentions:
    51. Adaptation of Mycobacterium tuberculosis to Impaired Host Immunity in HIV-Infected Patients. J Infect Dis. 2016 10 15; 214(8):1205-11. Walter ND, de Jong BC, Garcia BJ, Dolganov GM, Worodria W, Byanyima P, Musisi E, Huang L, Chan ED, Van TT, Antonio M, Ayorinde A, Kato-Maeda M, Nahid P, Leung AM, Yen A, Fingerlin TE, Kechris K, Strong M, Voskuil MI, Davis JL, Schoolnik GK. PMID: 27534685.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    52. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis. 2016 10 01; 63(7):e147-e195. Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A. PMID: 27516382.
      View in: PubMed   Mentions: 123     Fields:    Translation:HumansCellsPHPublic Health
    53. A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP). BMC Med. 2016 Mar 23; 14:51. Phillips PP, Dooley KE, Gillespie SH, Heinrich N, Stout JE, Nahid P, Diacon AH, Aarnoutse RE, Kibiki GS, Boeree MJ, Hoelscher M. PMID: 27004726.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    54. Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults. Int J Tuberc Lung Dis. 2016 Mar; 20(3):290-4. Furin J, Alirol E, Allen E, Fielding K, Merle C, Abubakar I, Andersen J, Davies G, Dheda K, Diacon A, Dooley KE, Dravnice G, Eisenach K, Everitt D, Ferstenberg D, Goolam-Mahomed A, Grobusch MP, Gupta R, Harausz E, Harrington M, Horsburgh CR, Lienhardt C, McNeeley D, Mitnick CD, Nachman S, Nahid P, Nunn AJ, Phillips P, Rodriguez C, Shah S, Wells C, Thomas-Nyang'wa B, du Cros P. PMID: 27046707.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    55. Challenges in the clinical assessment of novel tuberculosis drugs. Adv Drug Deliv Rev. 2016 07 01; 102:116-22. Dooley KE, Phillips PP, Nahid P, Hoelscher M. PMID: 26827911.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    56. A Blueprint to Address Research Gaps in the Development of Biomarkers for Pediatric Tuberculosis. Clin Infect Dis. 2015 Oct 15; 61Suppl 3:S164-72. Nicol MP, Gnanashanmugam D, Browning R, Click ES, Cuevas LE, Detjen A, Graham SM, Levin M, Makhene M, Nahid P, Perez-Velez CM, Reither K, Song R, Spiegel HM, Worrell C, Zar HJ, Walzl G. PMID: 26409279.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    57. Evaluation of mobile digital light-emitting diode fluorescence microscopy in Hanoi, Viet Nam. Int J Tuberc Lung Dis. 2015 Sep; 19(9):1068-72. Chaisson LH, Reber C, Phan H, Switz N, Nilsson LM, Myers F, Nhung NV, Luu L, Pham T, Vu C, Nguyen H, Nguyen A, Dinh T, Nahid P, Fletcher DA, Cattamanchi A. PMID: 26260826.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    58. In vitro immunomodulation for enhancing T cell-based diagnosis of Mycobacterium tuberculosis infection. Diagn Microbiol Infect Dis. 2015 Sep; 83(1):41-5. Slater M, Tran MC, Platt L, Luu LT, Phan HT, Pham PT, Do TB, Nguyen HT, Gaur RL, Parsonnet J, Cattamanchi A, Luo R, Nahid P, Banaei N. PMID: 26081239.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    59. Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis. Tuberculosis (Edinb). 2015 Jul; 95(4):415-20. Jayakumar A, Vittinghoff E, Segal MR, MacKenzie WR, Johnson JL, Gitta P, Saukkonen J, Anderson J, Weiner M, Engle M, Yoon C, Kato-Maeda M, Nahid P. PMID: 26022314.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsCTClinical Trials
    60. Towards tuberculosis elimination: an action framework for low-incidence countries. Eur Respir J. 2015 Apr; 45(4):928-52. Lönnroth K, Migliori GB, Abubakar I, D'Ambrosio L, de Vries G, Diel R, Douglas P, Falzon D, Gaudreau MA, Goletti D, González Ochoa ER, LoBue P, Matteelli A, Njoo H, Solovic I, Story A, Tayeb T, van der Werf MJ, Weil D, Zellweger JP, Abdel Aziz M, Al Lawati MR, Aliberti S, Arrazola de Oñate W, Barreira D, Bhatia V, Blasi F, Bloom A, Bruchfeld J, Castelli F, Centis R, Chemtob D, Cirillo DM, Colorado A, Dadu A, Dahle UR, De Paoli L, Dias HM, Duarte R, Fattorini L, Gaga M, Getahun H, Glaziou P, Goguadze L, Del Granado M, Haas W, Järvinen A, Kwon GY, Mosca D, Nahid P, Nishikiori N, Noguer I, O'Donnell J, Pace-Asciak A, Pompa MG, Popescu GG, Robalo Cordeiro C, Rønning K, Ruhwald M, Sculier JP, Simunovic A, Smith-Palmer A, Sotgiu G, Sulis G, Torres-Duque CA, Umeki K, Uplekar M, van Weezenbeek C, Vasankari T, Vitillo RJ, Voniatis C, Wanlin M, Raviglione MC. PMID: 25792630.
      View in: PubMed   Mentions: 133     Fields:    Translation:HumansPHPublic Health
    61. Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human Tuberculosis. J Infect Dis. 2015 Sep 15; 212(6):990-8. Walter ND, Dolganov GM, Garcia BJ, Worodria W, Andama A, Musisi E, Ayakaka I, Van TT, Voskuil MI, de Jong BC, Davidson RM, Fingerlin TE, Kechris K, Palmer C, Nahid P, Daley CL, Geraci M, Huang L, Cattamanchi A, Strong M, Schoolnik GK, Davis JL. PMID: 25762787.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    62. Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial. Am J Respir Crit Care Med. 2015 Feb 01; 191(3):333-43. Dorman SE, Savic RM, Goldberg S, Stout JE, Schluger N, Muzanyi G, Johnson JL, Nahid P, Hecker EJ, Heilig CM, Bozeman L, Feng PJ, Moro RN, MacKenzie W, Dooley KE, Nuermberger EL, Vernon A, Weiner M. PMID: 25489785.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    63. Detection of Mycobacterium tuberculosis peptides in the exosomes of patients with active and latent M. tuberculosis infection using MRM-MS. PLoS One. 2014; 9(7):e103811. Kruh-Garcia NA, Wolfe LM, Chaisson LH, Worodria WO, Nahid P, Schorey JS, Davis JL, Dobos KM. PMID: 25080351.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    64. Non-tuberculous mycobacterial infections at San Francisco General Hospital. Clin Respir J. 2015 Oct; 9(4):436-42. Sheu LC, Tran TM, Jarlsberg LG, Marras TK, Daley CL, Nahid P. PMID: 24799125.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    65. Childhood tuberculosis in northern Viet Nam: a review of 103 cases. PLoS One. 2014; 9(5):e97267. Blount RJ, Tran B, Jarlsberg LG, Phan H, Thanh Hoang V, Nguyen NV, Lewinsohn DA, Nahid P. PMID: 24818967.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    66. Pyrazinamide resistance, Mycobacterium tuberculosis lineage and treatment outcomes in San Francisco, California. PLoS One. 2014; 9(4):e95645. Budzik JM, Jarlsberg LG, Higashi J, Grinsdale J, Hopewell PC, Kato-Maeda M, Nahid P. PMID: 24759760.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    67. Point-of-care C-reactive protein testing to facilitate implementation of isoniazid preventive therapy for people living with HIV. . 2014 Apr 15; 65(5):551-6. Yoon C, Davis JL, Huang L, Muzoora C, Byakwaga H, Scibetta C, Bangsberg DR, Nahid P, Semitala FC, Hunt PW, Martin JN, Cattamanchi A. PMID: 24346636.
      View in: PubMed   Mentions:
    68. Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis. Tuberculosis (Edinb). 2014 May; 94(3):187-96. Nahid P, Bliven-Sizemore E, Jarlsberg LG, De Groote MA, Johnson JL, Muzanyi G, Engle M, Weiner M, Janjic N, Sterling DG, Ochsner UA. PMID: 24629635.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    69. Hepatotoxicity in Children Receiving Isoniazid Therapy for Latent Tuberculosis Infection. J Pediatric Infect Dis Soc. 2014 Sep; 3(3):221-7. Chang SH, Nahid P, Eitzman SR. PMID: 26625385.
      View in: PubMed   Mentions: 1     Fields:    
    70. Factors associated with failure to complete isoniazid therapy for latent tuberculosis infection in children and adolescents. J Infect Public Health. 2014 Mar-Apr; 7(2):145-52. Chang SH, Eitzman SR, Nahid P, Finelli ML. PMID: 24361084.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    71. Update in tuberculosis and nontuberculous mycobacterial disease 2012. Am J Respir Crit Care Med. 2013 Oct 15; 188(8):923-7. Menzies D, Nahid P. PMID: 24127799.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    72. Advances in the development of new tuberculosis drugs and treatment regimens. Nat Rev Drug Discov. 2013 May; 12(5):388-404. Zumla A, Nahid P, Cole ST. PMID: 23629506.
      View in: PubMed   Mentions: 185     Fields:    Translation:HumansCells
    73. Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment. PLoS One. 2013; 8(4):e61002. De Groote MA, Nahid P, Jarlsberg L, Johnson JL, Weiner M, Muzanyi G, Janjic N, Sterling DG, Ochsner UA. PMID: 23637781.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    74. Drug-resistant tuberculosis: time for visionary political leadership. Lancet Infect Dis. 2013 Jun; 13(6):529-39. Abubakar I, Zignol M, Falzon D, Raviglione M, Ditiu L, Masham S, Adetifa I, Ford N, Cox H, Lawn SD, Marais BJ, McHugh TD, Mwaba P, Bates M, Lipman M, Zijenah L, Logan S, McNerney R, Zumla A, Sarda K, Nahid P, Hoelscher M, Pletschette M, Memish ZA, Kim P, Hafner R, Cole S, Migliori GB, Maeurer M, Schito M, Zumla A. PMID: 23531391.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansCells
    75. Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium. J Infect Dis. 2012 Oct 01; 206(7):1030-40. Dorman SE, Goldberg S, Stout JE, Muzanyi G, Johnson JL, Weiner M, Bozeman L, Heilig CM, Feng PJ, Moro R, Narita M, Nahid P, Ray S, Bates E, Haile B, Nuermberger EL, Vernon A, Schluger NW. PMID: 22850121.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCellsCTClinical Trials
    76. Update in tuberculosis and nontuberculous mycobacterial disease 2011. Am J Respir Crit Care Med. 2012 Jun 15; 185(12):1266-70. Nahid P, Menzies D. PMID: 22707733.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsPHPublic Health
    77. Impact of isoniazid resistance-conferring mutations on the clinical presentation of isoniazid monoresistant tuberculosis. PLoS One. 2012; 7(5):e37956. Dantes R, Metcalfe J, Kim E, Kato-Maeda M, Hopewell PC, Kawamura M, Nahid P, Cattamanchi A. PMID: 22649569.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    78. Clinical research and development of tuberculosis diagnostics: moving from silos to synergy. J Infect Dis. 2012 May 15; 205 Suppl 2:S159-68. Nahid P, Kim PS, Evans CA, Alland D, Barer M, Diefenbach J, Ellner J, Hafner R, Hamilton CD, Iademarco MF, Ireton G, Kimerling ME, Lienhardt C, MacKenzie WR, Murray M, Perkins MD, Posey JE, Roberts T, Sizemore C, Stevens WS, Via L, Williams SD, Yew WW, Swindells S. PMID: 22476718.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    79. Anti-phospholipid antibody levels as biomarker for monitoring tuberculosis treatment response. Tuberculosis (Edinb). 2012 May; 92(3):243-7. Goodridge A, Cueva C, Lahiff M, Muzanye G, Johnson JL, Nahid P, Riley LW. PMID: 22406155.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    80. Mycobacterium tuberculosis lineage--what's in your lungs? Clin Infect Dis. 2012 Jan 15; 54(2):220-4. Kato-Maeda M, Nahid P. PMID: 22198990.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    81. Mycobacterial Infections in the non-HIV–Infected Patient. . 2012 Jan 1; 1478-1485. Melissa Nyendak, Tarek Eid, Payam Nahid, Kevin Winthrop, David Lewinsohn. .
      View in: Publisher Site   Mentions:
    82. Major Radiation Exposure. . 2012 Jan 1; 1351-1351. Denis D. Bensard, Philip F. Stahel, Jorge Cerdá, Babak Sarani, Sajid Shahul, Daniel Talmor, Peter M. Hammer, C. William Schwab, Steven Reynolds, Omar Ahmad, Tsuyoshi Kaneko, Anthony L. Estrera, William A. Knight, Bradley P. Dixon, Richard L. Gamelli, Joseph A. Posluszny, Mansoor N. Bangash, Rupert M. Pearse, Albert J. Ruggieri, Richard J. Levy, Clifford S. Deutschman, Clifford S. Deutschman, Richard J. Levy, Prasanna Simha Mohan Rao, John P. Kress, Sabino Scolletta, Norman E. McSwain, Jeffry L. Kashuk, Angela Sauaia, Ernest E. Moore, Per-Olof J. Hasselgren, Wade R. Smith, John T. Riehl, Denis D. Bensard, Philip F. Stahel, Berton R. Moed, B. Kirke Bieneman, Berton R. Moed, Clay C. Cothren, Ernest E. Moore, Nima Majlesi, Richard D. Shih, Eelco F. M. Wijdicks, Melissa Nyendak, Tarek Eid, Payam Nahid, Kevin Winthrop, David Lewinsohn, Julie P. Chou, Tom Lim, Andrew G. Lee, Christopher H. Mody, Tom Lim, Julie P. Chou, Christopher H. Mody, Nathan T. Mowery, Alexander L. Colonna, J. Wayne Meredith, Alain Combes, Jonathan R. Egan, Marino S. Festa, A. Montcriol, Y. Asencio, F. Kerbaul. .
      View in: Publisher Site   Mentions:
    83. CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap. Am J Respir Crit Care Med. 2011 Oct 15; 184(8):972-9. Nahid P, Saukkonen J, Mac Kenzie WR, Johnson JL, Phillips PP, Andersen J, Bliven-Sizemore E, Belisle JT, Boom WH, Luetkemeyer A, Campbell TB, Eisenach KD, Hafner R, Lennox JL, Makhene M, Swindells S, Villarino ME, Weiner M, Benson C, Burman W. PMID: 21737585.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    84. Racial differences in tuberculosis infection in United States communities: the coronary artery risk development in young adults study. Clin Infect Dis. 2011 Aug 01; 53(3):291-4. Nahid P, Horne DJ, Jarlsberg LG, Reiner AP, Osmond D, Hopewell PC, Bibbins-Domingo K. PMID: 21765079.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    85. Discriminating between latent and active tuberculosis with multiple biomarker responses. Tuberculosis (Edinb). 2011 May; 91(3):250-6. Frahm M, Goswami ND, Owzar K, Hecker E, Mosher A, Cadogan E, Nahid P, Ferrari G, Stout JE. PMID: 21393062.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    86. Higher-dose rifampin for the treatment of pulmonary tuberculosis: a systematic review. Int J Tuberc Lung Dis. 2011 Mar; 15(3):305-16. Steingart KR, Jotblad S, Robsky K, Deck D, Hopewell PC, Huang D, Nahid P. PMID: 21333096.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimals
    87. Sputum monitoring during tuberculosis treatment for predicting outcome Authors' reply. The Lancet Infectious Diseases. 2011 Mar 1; 11(3):160-161. David J Horne, Sarah E Royce, Masahiro Narita, Payam Nahid, Karen R Steingart. .
      View in: Publisher Site   Mentions:
    88. Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis. BMC Infect Dis. 2011 Jan 03; 11:1. Nahid P, Jarlsberg LG, Rudoy I, de Jong BC, Unger A, Kawamura LM, Osmond DH, Hopewell PC, Daley CL. PMID: 21199579.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    89. Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis. Lancet Infect Dis. 2010 Jun; 10(6):387-94. Horne DJ, Royce SE, Gooze L, Narita M, Hopewell PC, Nahid P, Steingart KR. PMID: 20510279.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCells
    90. Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis. PLoS One. 2010 May 20; 5(5):e10753. Nahid P, Bliven EE, Kim EY, Mac Kenzie WR, Stout JE, Diem L, Johnson JL, Gagneux S, Hopewell PC, Kato-Maeda M. PMID: 20505778.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    91. Novel hot spot of IS6110 insertion in Mycobacterium tuberculosis. J Clin Microbiol. 2010 Apr; 48(4):1422-4. Kim EY, Nahid P, Hopewell PC, Kato-Maeda M. PMID: 20147648.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    92. Evaluation of quantitative IFN-gamma response for risk stratification of active tuberculosis suspects. Am J Respir Crit Care Med. 2010 Jan 01; 181(1):87-93. Metcalfe JZ, Cattamanchi A, Vittinghoff E, Ho C, Grinsdale J, Hopewell PC, Kawamura LM, Nahid P. PMID: 19797760.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    93. Relapse associated with active disease caused by Beijing strain of Mycobacterium tuberculosis. Emerg Infect Dis. 2009 Jul; 15(7):1061-7. Burman WJ, Bliven EE, Cowan L, Bozeman L, Nahid P, Diem L, Vernon A. PMID: 19624921.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    94. Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis. Clin Infect Dis. 2009 Jan 15; 48(2):179-85. Cattamanchi A, Dantes RB, Metcalfe JZ, Jarlsberg LG, Grinsdale J, Kawamura LM, Osmond D, Hopewell PC, Nahid P. PMID: 19086909.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    95. Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis. Clin Vaccine Immunol. 2009 Feb; 16(2):260-76. Steingart KR, Dendukuri N, Henry M, Schiller I, Nahid P, Hopewell PC, Ramsay A, Pai M, Laal S. PMID: 19052159.
      View in: PubMed   Mentions: 75     Fields:    Translation:HumansCells
    96. Detailed analysis of the radiographic presentation of Mycobacterium kansasii lung disease in patients with HIV infection. Chest. 2008 Apr; 133(4):875-80. Cattamanchi A, Nahid P, Marras TK, Gotway MB, Lee TJ, Gonzalez LC, Morris A, Webb WR, Osmond DH, Daley CL. PMID: 18263685.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    97. Tuberculosis Treatment. International Encyclopedia of Public Health. 2008 Jan 1; 397-408. P. Nahid, P.C. Hopewell. .
      View in: Publisher Site   Mentions:
    98. Tuberculosis. Emergency Management of Infectious Diseases. 2008 Jan 1; 175-184. Adithya Cattamanchi, Payam Nahid. .
      View in: Publisher Site   Mentions:
    99. On Treatment Outcomes of Patients with HIV and Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 2008 Jan 1; 177(1):121-122. Payam Nahid, Bouke C. de Jong, Charles L. Daley. .
      View in: Publisher Site   Mentions:
    100. Efficacy of nurse case-managed intervention for latent tuberculosis among homeless subsamples. Nurs Res. 2008 Jan-Feb; 57(1):33-9. Nyamathi A, Nahid P, Berg J, Burrage J, Christiani A, Aqtash S, Morisky D, Leake B. PMID: 18091290.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    101. Reaching the limits of tuberculosis prevention among foreign-born individuals: a tuberculosis-control program perspective. Clin Infect Dis. 2008 Jan 01; 46(1):103-6. Walter ND, Jasmer RM, Grinsdale J, Kawamura LM, Hopewell PC, Nahid P. PMID: 18171222.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    102. Treatment outcomes of patients with HIV and tuberculosis. Am J Respir Crit Care Med. 2007 Jun 01; 175(11):1199-206. Nahid P, Gonzalez LC, Rudoy I, de Jong BC, Unger A, Kawamura LM, Osmond DH, Hopewell PC, Daley CL. PMID: 17290042.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    103. Unusual finding on bronchoscopy: trauma patient identified as a body stuffer. J Clin Anesth. 2006 Dec; 18(8):628-30. Chang C, Grush A, McClintock DE, Nahid P, Tang JF. PMID: 17175436.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    104. A randomized controlled trial of two treatment programs for homeless adults with latent tuberculosis infection. Int J Tuberc Lung Dis. 2006 Jul; 10(7):775-82. Nyamathi AM, Christiani A, Nahid P, Gregerson P, Leake B. PMID: 16848340.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    105. Prevention of tuberculosis in HIV-infected patients. Curr Opin Infect Dis. 2006 Apr; 19(2):189-93. Nahid P, Daley CL. PMID: 16514345.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    106. Advances in the diagnosis and treatment of tuberculosis. Proc Am Thorac Soc. 2006; 3(1):103-10. Nahid P, Pai M, Hopewell PC. PMID: 16493157.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    107. Clinical practice. Latent tuberculosis infection. N Engl J Med. 2002 Dec 05; 347(23):1860-6. Jasmer RM, Nahid P, Hopewell PC. PMID: 12466511.
      View in: PubMed   Mentions: 92     Fields:    Translation:Humans